Skip to content

13F-HR filed by Avoro Capital Advisors LLC

Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 32 holding rows worth $10,164,789,055.

Accession
0001104659-26-061754
Filed
2026-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 33 entries on the cover page, a total value of $10,164,789,055 stated on the cover page (in dollars after the unit check, H1), rows summing to $10,164,789,055 with VALUE read as dollars as filed, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
UNITED THERAPEUTICS CORP DEL COM91307C102Stock2,630,000$1,559,537,400dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR5,062,500$1,157,945,625dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock1,818,181$951,763,208dollars as filed
KRYSTAL BIOTECH INC COM501147102Stock2,888,888$746,257,548dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR1,000,000$730,250,000dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM10,699,999$670,889,937dollars as filed
KYMERA THERAPEUTICS INC501575104COM7,474,747$622,571,678dollars as filed
APELLIS PHARMACEUTICALS INC03753U106COM12,222,222$491,699,991dollars as filed
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS11,430,455$454,017,673dollars as filed
CELCUITY INC15102K100COM3,375,000$385,222,500dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock5,777,777$335,977,733dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY6,555,555$315,977,751dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock5,695,000$300,240,400dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK5,888,888$236,909,964dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock2,344,444$227,997,179dollars as filed
CYTOKINETICS INC23282W605COM NEW3,333,333$219,699,978dollars as filed
OCULAR THERAPEUTIX INC67576A100COM12,315,000$104,308,050dollars as filed
DAMORA THERAPEUTICS INC36322Q206COMMON STOCK3,783,000$97,979,700dollars as filed
UNIQURE NVN90064101SHS5,959,595$97,439,378dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK21,700,000$96,999,000dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS5,000,000$94,500,000dollars as filed
SOLENO THERAPEUTICS INC834203309COM2,300,000$77,004,000dollars as filed
ALKERMES PLCG01767105SHS1,200,000$42,432,000dollars as filed
SEPTERNA INC COM81734D104Stock1,337,500$32,140,125dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM1,500,000$29,340,000dollars as filed
GH RESEARCH PLC ORDINARY SHARESG3855L106Stock1,800,000$25,308,000dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK1,410,000$21,051,300dollars as filed
LEXEO THERAPEUTICS INC52886X107COMMON STOCK1,875,000$10,762,500dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock380,000$10,296,000dollars as filedcall
WHITEHAWK THERAPEUTICS INC00032Q104CMN2,849,402$9,830,437dollars as filed
MANNKIND CORP COM NEW56400P706Stock2,200,000$5,390,000dollars as filed
CELCUITY INC15102K100COM200,000$3,050,000dollars as filedcall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-26-061754this filing2026-05-15acceptance time not in the bulk data set